CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands	Jun. 30, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 29,055	$ 37,099
Restricted cash	275	308
Accounts receivable and unbilled, net (includes $1.2 million and $2.3 million with related parties at June 30, 2017 and December 31, 2016, respectively)	76,664	79,767
Prepaid expenses and other current assets	17,129	16,074
Total current assets	123,123	133,248
Property and equipment, net	45,244	43,805
Goodwill	660,981	660,981
Intangible assets, net	117,676	136,071
Deferred income taxes	11,536	97
Other assets	5,086	4,903
Total assets	963,646	979,105
Current liabilities:
Accounts payable	7,195	10,911
Accrued expenses	16,392	24,417
Pre-funded study costs (includes $1.5 million and $3.9 million with related parties at June 30, 2017 and December 31, 2016, respectively)	48,530	51,948
Advanced billings (includes $4.2 million and $7.6 million with related parties at June 30, 2017 and December 31, 2016, respectively)	65,577	65,668
Current portion of long-term debt	14,438	12,375
Other current liabilities	3,130	3,284
Total current liabilities	155,262	168,603
Long-term debt, net, less current portion	143,191	151,267
Deemed landlord liability, less current portion	27,591	28,527
Deferred income tax liability	481	12,030
Deferred credit	21,420
Other long-term liabilities	8,343	7,968
Total liabilities	356,288	368,395
Commitments and contingencies (see Note 11)
Shareholders’ equity:
Preferred stock - $0.01 par-value; 5,000,000 shares authorized; no shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively
Common stock - $0.01 par-value; 250,000,000 shares authorized at June 30, 2017 and December 31, 2016, respectively; 39,692,999 and 40,662,856 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively	398	407
Additional paid-in capital	627,407	623,629
Accumulated deficit	(18,419)	(9,584)
Accumulated other comprehensive loss	(2,028)	(3,742)
Total shareholders’ equity	607,358	610,710
Total liabilities and shareholders’ equity	$ 963,646	$ 979,105